208 related articles for article (PubMed ID: 6330391)
41. [Distribution of cefotiam dihydrochloride to the bloodless lung].
Fujimoto Y; Monden Y; Nakahara K; Nanjo S; Ohno K; Fujii Y; Hashimoto J; Kitagawa Y; Miyoshi S; Maeda H
Jpn J Antibiot; 1985 Jan; 38(1):155-9. PubMed ID: 3857358
[TBL] [Abstract][Full Text] [Related]
42. [Evaluation of cefotiam in pediatric field (author's transl)].
Iwai N; Sasaki A; Taneda Y; Inokuma K
Jpn J Antibiot; 1981 Jun; 34(6):1002-18. PubMed ID: 6270417
[TBL] [Abstract][Full Text] [Related]
43. [Transportation of cefotiam from serum to lung tissue].
Shimizu N; Kunikata E; Kurita K; Hara F; Teramoto S
Jpn J Antibiot; 1983 May; 36(5):1133-6. PubMed ID: 6312118
[TBL] [Abstract][Full Text] [Related]
44. [Chemotherapy in biliary tract infections (XXX). Special reference to the concentration of micronomicin in human gallbladder tissues and bile].
Tanimura H; Mukaihara S; Setoyama M; Yung M; Kato H; Yotsumoto F; Nakano M
Jpn J Antibiot; 1985 Nov; 38(11):3087-96. PubMed ID: 4094048
[TBL] [Abstract][Full Text] [Related]
45. Placental transfer of cefotiam dihydrochloride.
Miyakawa I; Inoue H; Kuroki T; Lee HC; Azegami M; Mori N
Antimicrob Agents Chemother; 1984 Jan; 25(1):147-8. PubMed ID: 6322677
[TBL] [Abstract][Full Text] [Related]
46. Biliary excretion and concentration of cefazolin.
Ram MD; Watanatittan S
Am J Gastroenterol; 1976 Dec; 66(6):540-5. PubMed ID: 1020741
[TBL] [Abstract][Full Text] [Related]
47. [Cefotiam concentration in exudate from suction drain of patients with breast cancer following intravenous administration].
Hashimoto I; Sawada Y; Nakamura T; Mikami J; Nishindai H; Yoshimoto M; Nakanishi Y; Fugono T; Maeda K
Jpn J Antibiot; 1986 Jan; 39(1):99-108. PubMed ID: 3457965
[TBL] [Abstract][Full Text] [Related]
48. Concentration of cefixime in bile, gallbladder wall and serum after preoperative administration in patients undergoing cholecystectomy.
Moorthi K; Fleckenstein G; Nies B
Methods Find Exp Clin Pharmacol; 1990 May; 12(4):287-90. PubMed ID: 2374476
[TBL] [Abstract][Full Text] [Related]
49. [Penetration of cefotiam dihydrochloride into cerebrospinal fluid (author's transl)].
Kojima T; Waga S; Morikawa A; Okada M; Furuno M; Shimizu T
Jpn J Antibiot; 1982 Apr; 35(4):1063-7. PubMed ID: 6285024
[TBL] [Abstract][Full Text] [Related]
50. Cefotiam concentrations in bile and in the wall of the gallbladder in patients with biliary disease.
Satake K; Cho K; Taniura M; Oka I; Koo I
J Antimicrob Chemother; 1982 Aug; 10(2):141-5. PubMed ID: 6288652
[No Abstract] [Full Text] [Related]
51. [Pharmacokinetic and clinical studies of cefotiam in the perinatal period].
Cho N; Fukunaga K; Kunii K
Jpn J Antibiot; 1986 Sep; 39(9):2488-96. PubMed ID: 3467090
[TBL] [Abstract][Full Text] [Related]
52. [A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients].
Hukagawa H; Noga K
Jpn J Antibiot; 1992 Mar; 45(3):253-7. PubMed ID: 1512921
[TBL] [Abstract][Full Text] [Related]
53. [Studies on cefotaxime (HR 756) concentration in human biliary tract and clinical effect for acute or subacute cholecystitis with cholelithiasis (author's transl)].
Kasai Y; Nakanishi M; Sawada Y; Nakamura T; Hashimoto I; Mikami J; Bekki E; Hirasawa S; Abe H; Kasai K; Omosu M
Jpn J Antibiot; 1981 Mar; 34(3):447-52. PubMed ID: 6270392
[TBL] [Abstract][Full Text] [Related]
54. Biliary excretion of ceftizoxime in humans.
Brogard JM; Arnaud JP; Timmler R
Chemotherapy; 1984; 30(4):221-6. PubMed ID: 6086245
[TBL] [Abstract][Full Text] [Related]
55. [Pharmacokinetics and clinical evaluation of cefotiam in pediatric surgery].
Yura J; Tsuruga N; Hashimoto T; Kamiya Y; Hayashi S; Murata Y
Jpn J Antibiot; 1986 Sep; 39(9):2483-7. PubMed ID: 3467089
[TBL] [Abstract][Full Text] [Related]
56. [Cefotiam excretion into biliary tract and ascites in abdominal operations].
Tanaka I; Hosoma S; Osiro H; Yamamoto Y; Sugino K; Sumimoto K; Kishi N
Jpn J Antibiot; 1983 Jan; 36(1):76-83. PubMed ID: 6302346
[No Abstract] [Full Text] [Related]
57. [Fundamental and clinical studies of cefotiam in neonates and premature infants].
Motohiro T; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Kuda N
Jpn J Antibiot; 1986 Sep; 39(9):2466-82. PubMed ID: 3467088
[TBL] [Abstract][Full Text] [Related]
58. [Study of lincomycin concentrations in hepatocystic duct].
Ishikawa T; Kitajima M; Tatekawa I; Sohma S; Deguchi K; Fukayama S; Nishimura Y; Nishike A
Jpn J Antibiot; 1984 Oct; 37(10):1766-72. PubMed ID: 6502929
[TBL] [Abstract][Full Text] [Related]
59. [Pharmacokinetics of cefotiam in patients undergoing continuous ambulatory peritoneal dialysis].
Itagaki N; Hasegawa H; Tsujino M; Takahashi K; Yamamoto Y; Imada A; Horiuchi A
Jpn J Antibiot; 1988 Apr; 41(4):405-8. PubMed ID: 3165474
[TBL] [Abstract][Full Text] [Related]
60. [Cefotiam concentration in exudates from the drainage of patients with acute peritonitis following intravenous administration].
Nishindai H; Yoshimoto M; Nakanishi Y; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Fugono T; Maeda K
Jpn J Antibiot; 1985 Jun; 38(6):1571-86. PubMed ID: 3862880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
